top of page
Blog
Tahoe Bio Raised $30M To Build AI Models Of Living Cells
The Palo Alto, California-based company, now valued at $120 million, has developed a scalable way to quickly generate crucial biological data needed for AI models–and use them to find new cures for cancer.
Aug 111 min read
Gordon To Leave Oxford Nanopore
Gordon is stepping down as CEO of Oxford Nanopore and is set to leave the post before the end of 2026.
Aug 111 min read
10x Genomics Acquires Scale Biosciences to Boost Single-Cell Capabilities
10x Genomics is acquiring Scale Biosciences in a $30M cash-and-stock deal plus milestones.
Aug 71 min read
Sanger and PacBio Launch Long-Read Effort to Decode Immune Gene Activity
Sanger and PacBio will apply long read scRNA sequencing to identify RNA isoforms, using PacBio’s HiFi long-read technology to provide high-resolution maps.
Apr 151 min read
bottom of page